Eyecarrot Announces Its Common Shares Are Now Listed on the OTCQB Under the Symbol EYCCF

Last Updated: June 8, 2017

Toronto, Ontario – Eyecarrot Innovations Corp (TSX-V: EYC | OTCQB: EYCCF) (“Eyecarrot” or “the Company”) is pleased to announce that the Company’s common shares have started trading on the otcqb, under the symbol “eyccf“. Investors can now trade with access to real-time Level 2 quotes and view the Company’s current financial disclosure and other documents by visiting otcqb.

The Company is also pleased to report that the Company has received approval from The Depository Trust Company (dtc) that the Company’s shares are dtc eligible.

“Achieving dtc eligibility to simplify trading of Eyecarrot shares on the otcqb provides the Company access to a broad range of investors within the U.S. while having a more transparent and efficient quotation and trading platform for our U.S. shareholder base.”

Adam Cegielski, President and CEO

About Eyecarrot

Eyecarrot’s Binovitm platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient’s experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.

Forward Looking Information

Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

source Eyecarrot Innovations Corp.

For further information: Adam Cegielski, President CEO, Telephone: 1.855.416.7158416.943.6271